Search research articles
Contact Us
Filters
Showing results (241-250 of 632) with videos related to
Page
of 64
Sort By:
Alimentary Pharmacology & Therapeutics
|
December 4, 2024
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
Toni Herta, Anna Joachim-Richter, David Petroff, et al.
Scandinavian Journal of Gastroenterology
|
June 2, 2020
Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
Florian Gerhardt, David Petroff, Valentin Blank, et al.
Journal of Hepatology
|
July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Philippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2007
Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis
Katja Derkow, Christoph Loddenkemper, Justine Mintern, et al.
Journal of Hepatology
|
November 30, 2010
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
Christoph Sarrazin, Simone Susser, Alexandra Doehring, et al.
Cells
|
August 6, 2020
Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
Luise Spormann, Christiane Rennert, Erik Kolbe, et al.
Journal of Digestive Diseases
|
March 23, 2022
Yttrium-90 radioembolization-induced abscopal effect on hepatocellular carcinoma
Karen Geva Steinhoff, Tim-Ole Petersen, Sandra Purz, et al.
Human Immunology
|
December 16, 2010
A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection
Iris Lettow, Marie-Luise Berres, Petra Schmitz, et al.
The Lancet. Neurology
|
October 14, 2008
Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial
Mats Engström, Thomas Berg, Anna Stjernquist-Desatnik, et al.
Journal of Hepatology
|
July 16, 2005
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection
Christoph Sarrazin, Thomas Berg, Viola Weich, et al.
Page
of 64
Search research articles
Search
Showing results (241-250 of 632) with videos related to
Sort By:
Page
of 64
Alimentary Pharmacology & Therapeutics
|
December 4, 2024
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
Toni Herta, Anna Joachim-Richter, David Petroff, et al.
Scandinavian Journal of Gastroenterology
|
June 2, 2020
Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
Florian Gerhardt, David Petroff, Valentin Blank, et al.
Journal of Hepatology
|
July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Philippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2007
Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis
Katja Derkow, Christoph Loddenkemper, Justine Mintern, et al.
Journal of Hepatology
|
November 30, 2010
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
Christoph Sarrazin, Simone Susser, Alexandra Doehring, et al.
Cells
|
August 6, 2020
Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
Luise Spormann, Christiane Rennert, Erik Kolbe, et al.
Journal of Digestive Diseases
|
March 23, 2022
Yttrium-90 radioembolization-induced abscopal effect on hepatocellular carcinoma
Karen Geva Steinhoff, Tim-Ole Petersen, Sandra Purz, et al.
Human Immunology
|
December 16, 2010
A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection
Iris Lettow, Marie-Luise Berres, Petra Schmitz, et al.
The Lancet. Neurology
|
October 14, 2008
Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial
Mats Engström, Thomas Berg, Anna Stjernquist-Desatnik, et al.
Journal of Hepatology
|
July 16, 2005
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection
Christoph Sarrazin, Thomas Berg, Viola Weich, et al.
Page
of 64